Macrophage secretory IL-1β promotes docetaxel resistance in head and neck squamous carcinoma via SOD2/CAT-ICAM1 signaling

Docetaxel (DTX) combined with cisplatin and 5-fluorouracil has been used as induction chemotherapy for head and neck squamous cell carcinoma (HNSCC). However, the development of acquired resistance remains a major obstacle to treatment response. Tumor-associated macrophages are associated with chemo...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Ching-Yun Hsieh, Ching-Chan Lin, Yu-Wen Huang, Jong-Hang Chen, Yung-An Tsou, Ling-Chu Chang, Chi-Chen Fan, Chen-Yuan Lin, Wei-Chao Chang
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	American Society for Clinical investigation 2022-12-01
Cyfres:	JCI Insight
Pynciau:	Oncology
Mynediad Ar-lein:	https://doi.org/10.1172/jci.insight.157285
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!